|
BIOSENSE WEBSTER INC OPTRELL MAPPING CATHETER WITH TRUEREF TECHNOLOGY; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
|
Back to Search Results |
|
| Catalog Number |
D142901 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/18/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a cardiac ablation procedure with a optrell mapping catheter with trueref technology and an infusion alarm sounded.During pre-mapping, an alarm for infusion pump blockage sounded.Although the catheter was pulled from the patient's body, straightened, and infused again outside the patient's body and transfused again, but the alarm did not stop.The issue was addressed by replacing the catheter with a new optrell but the alert occurred at the time of flushing before inserting the catheter into the patient's body.Since perfusion was achieved, continued use was permitted with the physician's approval.
|
| |
|
Additional Manufacturer Narrative
|
|
On 18-mar-2025, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
It was reported that a patient underwent a cardiac ablation procedure with a optrell mapping catheter with trueref technology and an infusion alarm sounded.During pre-mapping, an alarm for infusion pump blockage sounded.Although the catheter was pulled from the patient's body, straightened, and infused again outside the patient's body and transfused again, but the alarm did not stop.The issue was addressed by replacing the catheter with a new optrell but the alert occurred at the time of flushing before inserting the catheter into the patient's body.Since perfusion was achieved, continued use was permitted with the physician's approval.Device evaluation details: the device was returned to johnson & johnson medtech (j&j medtech) for evaluation.A visual inspection and irrigation test of the returned device were performed following j&j medtech procedures.Visual analysis revealed no damage or anomalies on the device.An irrigation test was performed, and the device was flushing correctly.No irrigation issues were observed.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer could not be replicated during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.The instructions for use contain the following recommendations: flush the catheter with heparinized saline prior to insertion into the body.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|